首页> 美国卫生研究院文献>Inquiry: A Journal of Medical Care Organization Provision and Financing >A Statewide Evaluation of the California Medical Supervision Program Using Cholinesterase Electronic Laboratory Reporting Data
【2h】

A Statewide Evaluation of the California Medical Supervision Program Using Cholinesterase Electronic Laboratory Reporting Data

机译:使用胆碱酯酶电子实验室报告数据对加州医学监督计划进行全州评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The California Medical Supervision program is designed to protect workers who regularly mix, load, or apply the highly toxic Category I and II organophosphates and carbamates from overexposure by monitoring cholinesterase (ChE) inhibition in plasma and red blood cells. Since January 2011, testing laboratories are required to report test results electronically to the California Department of Pesticide Regulation who shares it with the Office of Environmental Health Hazard Assessment for evaluation. The purpose of this study is to assess the utility of this reporting in evaluating the effectiveness of the Program for illness surveillance and prevention. From 2011 to 2013, we received more than 90 000 test results. Despite data gaps and data quality issues, we were able to perform spatial and temporal analyses and developed a screening tool to identify individuals potentially at risk of overexposure. The data analysis provided some evidence that the Program is effective in protecting agricultural workers handling the most toxic ChE-inhibiting pesticides even though it also identified some areas of potential concerns with individuals that appeared lacking corrective actions in the workplace in response to excessive ChE depressions and parts of the state with disproportionately at-risk individuals. However, changes to the electronic reporting are needed to more accurately identify tests related to the Program and therefore improve the utility of the data received. Moreover, data analysis also revealed that electronic reporting has its limitation in evaluating the Program.
机译:加州医学监督计划旨在通过监测血浆和红细胞对胆碱酯酶(ChE)的抑制作用,保护定期混合,装载或施用剧毒的I和II类有机磷酸酯和氨基甲酸酯的工人,避免过度暴露。自2011年1月起,测试实验室必须以电子方式将测试结果报告给加利福尼亚农药管理部门,该部门将其与环境健康危害评估办公室共享以进行评估。这项研究的目的是评估该报告在评估该计划对疾病监测和预防的有效性中的效用。从2011年到2013年,我们收到了90,000多个测试结果。尽管存在数据缺口和数据质量问题,我们仍能够进行时空分析并开发了一种筛选工具,以识别可能面临过度暴露风险的个人。数据分析提供了一些证据,表明该计划有效地保护了处理最具毒性的抑制ChE农药的农业工人,尽管该计划还确定了一些个人可能担心的领域,这些个人似乎在工作场所因过度的ChE抑郁和抑郁而缺乏纠正措施。该州部分地区的个人风险比例过高。但是,需要对电子报告进行更改以更准确地识别与本程序有关的测试,从而提高接收到的数据的实用性。此外,数据分析还显示,电子报告在评估计划方面有其局限性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号